UFP Technologies, Inc. (NASDAQ: UFPT) has lost 7.7% of its price or $1.58 to settle at $18.93 with a moderate volume of 763,500 shares. The stock has recently touched its 52-week high of $21.59 before tumbling to the $18 range. Stock's daily volatility was between $18.10 and $21.59 and its 52-week range has been between $7.26 and $21.59. The stock has a market cap of $117 million, PE of 13.88 and an EPS of $1.36
UFP Technologies, Inc. (UFPT) designs and manufactures engineered packaging solutions utilizing molded fiber, vacuum-formed plastics and molded fiber. The Company also designs and manufactures engineered component products using laminating, molding and fabricating technologies. UFPT serves manufacturing sectors, but targets opportunities in the medical and scientific, automotive, aerospace and defense, computer and electronics, industrial, and consumer markets. The Company's packaging solutions are made primarily from polyethylene and polyurethane foams, and a range of sheet plastics.
Elite Pharmaceuticals Inc. (OTCBB: ELTP) has advanced 9.26% or one cent to settle at six cents a share with an increased volume of 4.5 million shares compared to its average three-month volume of 1,033,000 shares. Stock has been trading above its 50-day moving average of $0.0455 and it's about to surpass its resistance of 200-day moving average of $0.0585 with a relative strength index of 69.88.
Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company principally engaged in the development and manufacture of oral, controlled-release products, using technology. The Company has two products: Lodrane 24 and Lodrane 24D, being sold commercially. It also has an approved generic methadone product developed with its partner. The PharmaNetwork. Elite manufactures two once-daily allergy products, Lodrane 24 and Lodrane 24D, that were co-developed with its partner, ECR Pharmaceuticals (ECR). The products are being marketed by ECR. Elite's revenues for manufacturing these products and a royalty on sales for the fiscal year ended March 31, 2010 (fiscal 2010), aggregated $3,339,870.
STEC, Inc. (NASDAQ: STEC) has lost 0.46% or $.11 to settle at $23.68 with an increased volume of 6,026,155 shares compared to its average three-month volume of 1,841,000 shares. The stock has been trending nicely above its 50 day moving average of 19.84 and has been trading way above its 200 day moving average of 15.25 with a relative strength index of 68.01.
STEC, Inc. is a global provider of enterprise-class Flash solid-state drives (SSDs) for enterprise-storage systems and servers that companies use to retain and access their critical data. The Company's products are designed specifically for storage systems and servers that run applications requiring a high level of input/output operations per second (IOPS) performance, capacity, reliability and low latency. STEC designs and develops its SSD controllers, enhance them with its own firmware and combine them with third-party Flash memory.
iRobot Corporation (NASDAQ: IRBT) has remained weak dropping 3.04% or $.91 to settle at $28.99 a share with a moderate volume of 219,969 shares compared to its average three-month volume of 187,933 shares. The stock has been in an uptrend bouncing off of its 50 day moving average of 25.33 and its 200 day moving average of 20.86 with a relative strength index of 69.22.
iRobot Corporation designs and builds robots. The Company's Roomba floor vacuuming robots, Scooba floor washing robot and Looj gutter cleaning robot perform domestic chores. Its PackBot and small unmanned ground vehicle (SUGV) tactical ground military robots perform battlefield reconnaissance and bomb disposal. Its Negotiator ground robot performs multi-purpose tasks for local police and first responders. iRobot's Seaglider unmanned underwater robot performs oceanic missions. The Company sells its robots to consumers through a variety of distribution channels, including chain stores and other national retailers, and its online store, and to the United States military and other government agencies worldwide.
Financial Engines, Inc. (NASDAQ: FNGN) has surged 5.09% or one dollars and $.25 to settle at $25.81 a share within moderate volume of 173,730 shares compared to its average three-month volume of 357,381 shares. The company has a market capitalization of $1.08 billion and a P/E ratio of 23.59 with an EPS of $1.09 for the past 12 months. .
Financial Engines, Inc. (Financial Engines) is a provider of independent, technology-enabled portfolio management services, investment advice and retirement help to participants in employer-sponsored defined contribution retirement plans, such as 401(k) plans. The Company helps investors plan for retirement by offering personalized plans for saving and investing, as well as by providing assessments of retirement income needs and readiness, regardless of the investor's personal wealth or investment account size. It uses advice technology platform to provide services to retirement plan participants.
OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. Always do you own homework before investing in any stock.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCpicks.com has not been compensated for any stocks listed in this stock news report